A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps

I8B-FW-ITRF -

The purpose of this study is to investigate how the human body processes LY900014 and its effect on blood sugar levels when it is delivered via an insulin pump to participants with type 1 diabetes mellitus. Side effects and tolerability will be documented.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Type 1 Diabetes
What the trial is testing?
Insulin Lispro, LY900014
Could I receive a Placebo?
No
Enrollment Goal
30
Trial Dates
Mar 1, 2016 - Aug 1, 2016
How long will I be in the trial?
Your participation could last up to 11 weeks and include 12 visits to the study center.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.